Camargo
DECEMBER 22, 2021
For example, streamlined programs can be limited to literature searches, nonclinical studies, demonstration of bioequivalence to an approved product, or a combination of nonclinical and bioequivalence studies, and their relatively low costs may be appealing. Scientist, Regulatory Strategy. Biowaiver Eligibility.
Pharmaceutical Technology
OCTOBER 28, 2022
They inform industrial scientists what is necessary to ensure that their product meets the safety and efficacy requirements to get a product approved in humans. For companies in the US, if the results show bioequivalence, an abbreviated new drug application (ANDA) containing the results is sent to the FDA to review and potentially approve.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Camargo
FEBRUARY 10, 2021
Pharmacokinetics (PK) and bioequivalence (BE) studies serve as the foundation of determining the fate of drug products. Pharmacokinetics Scientist. Drug development is an extremely cumbersome process, requiring the testing of an agent from in vitro studies to in vivo studies to in silico modeling. Co-Authors: Galina Bernstein, PhD.
Pharmaceutical Technology
JANUARY 6, 2023
It requires having access to proper techniques and skill sets, state-of-the-art equipment, process scientists and engineers who have a deep understanding of Quality by Design (QbD) principles, and methods for product and process characterisation. In vitro release testing to demonstrate bioequivalence.
Pharmaceutical Technology
FEBRUARY 23, 2023
Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. Quotient Sciences helps biotech and pharma customers in the development and optimization of drug products.
Expert insights. Personalized for you.
169 
Let's personalize your content